Sign in to follow
Search Results

0 results for 'CVS Caremark'

You can use to get even better search results
September 25, 2024 | National Law Journal

Express Scripts' Defamation Case Against FTC Will Fall Short, Law Professor Says

"It's not uncommon that a defamation suit is brought, not necessarily because the plaintiff expects to take it to trial, but instead, because they want to make a public announcement that what was said about them is wrong," said Lyrissa Lidsky, a University of Florida law professor.
3 minute read
September 20, 2024 | National Law Journal

FTC Takes Legal Action Against Three Largest PBMs Over High Insulin Prices

"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed," said Rahul Rao, deputy director of the FTC's Bureau of Competition.
6 minute read
September 17, 2024 | Law.com

Cigna's Express Scripts Sues Federal Trade Commission

"The FTC has taken unconstitutional actions in publishing a report that ignores the evidence provided by our company and other [pharmacy benefit managers], demonstrates clear ideological bias and advances a false and damaging narrative—narrative that could harm the health care system by removing essential checks and balances which would result in higher drug prices for American consumers," The Cigna Group Chief Legal Officer Andrea Nelson said.
3 minute read
September 17, 2024 | National Law Journal

Cigna's Express Scripts Sues FTC Over Allegedly Defamatory Report

"The FTC has taken unconstitutional actions in publishing a report that ignores the evidence provided by our company and other [pharmacy benefit managers]," said Andrea Nelson, Cigna Group's chief legal officer.
3 minute read
August 23, 2024 | The Recorder

Former CVS Exec Faces Trade Secrets Suit for Allegedly Helping Chickasaw Nation Case

Former CVS executive Adam Korn allegedly divulged confidential information about the company's reimbursement practices to support a suit filed by the Chickasaw Nation.
3 minute read
Law Journal Press | Digital Book Florida Construction Defect Litigation 2025 Authors: Gary L. Brown View this Book

View more book results for the query "CVS Caremark"

July 09, 2024 | National Law Journal

PBMs' Actions Might Increase Drug Prices, Drive Out Independent Pharmacies, FTC Reports

The agency voted 4-1 to issue the report on pharmacy benefit managers, with Republican Commissioner Melissa Holyoak being the sole dissenter.
6 minute read
April 23, 2024 | Connecticut Law Tribune

Civil RICO Suit Accuses Big Pharma and Benefit Managers of Insulin Price-Fixing

"Rather than working to lower insulin and other Type 2 diabetes medication prices, major [pharmacy benefit managers] and manufacturers use their dominant market positions to drastically increase the price of these necessary, life-saving medications, generating billions of dollars in illicit profits," co-lead counsel for the plaintiff claimed in a joint statement.
4 minute read
December 15, 2023 | Daily Report Online

Opioid Defendant Motions to Disqualify Motley Rice Over Alleged Ethical Concerns

OptumRx, a pharmacy benefit manager facing trials over its role in the opioid crisis, has moved to disqualify Motley Rice, citing alleged ethical violations tied to confidential information the law firm received through government subpoenas.
5 minute read
December 15, 2023 | Law.com

Opioid Defendant Moves to Disqualify Motley Rice Over Alleged Ethical Concerns

OptumRx, a pharmacy benefit manager facing trials over its role in the opioid crisis, has moved to disqualify Motley Rice, citing alleged ethical violations tied to confidential information the law firm received through government subpoenas.
5 minute read
December 11, 2023 | New York Law Journal

Upping the Dosage: Health Care and Pharmaceuticals Antitrust Regulation in 2023

Antitrust developments in the health care and pharmaceutical industries were exceptionally active in 2023. From the FTC's challenge of a merger between Amgen and Horizon Therapeutics, to joint agency withdrawal of well-established health care merger policy statements, to agency interest in pharmacy benefit managers, the authors review some of the most notable antitrust activity in the health care and pharmaceutical industries over the past year.
10 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Strong & Hanni Solves Storage Woes--Learn How You Can, Too

    Brought to you by Filevine

    Download Now

  • Meeting the Requirements of California's SB 553: Workplace Violence Prevention

    Brought to you by NAVEX Global

    Download Now

  • The Benefits of Outsourcing Beneficial Ownership Information Filing

    Brought to you by Wolters Kluwer

    Download Now

  • The Top 10 AI Use Cases in Private Equity

    Brought to you by Ontra

    Download Now